Introduction of traditional products of listed companies

Our reporter Pei Hong correspondent Sudan

"Traditional Chinese medicine decoction pieces, due to the objective differences between their natural resources and the shape of the primary processed products, have always had stubborn diseases such as inconsistent quality standards, uncontrollable drug quality and unstable drug performance. In the traditional decoction method, only 65,438+00%-30% of the pharmaceutical ingredients in Chinese herbal pieces can be effectively utilized, which has become a bottleneck restricting the development of Chinese medicine industry. " Cheng, chief engineer of CIIC Pharmaceutical Group (hereinafter referred to as CIIC Pharmaceutical), introduced to the reporter of China Intellectual Property News. In view of these shortcomings, in recent years, Zhongzhi Pharmaceutical has actively explored and tried to realize the innovative development of Chinese herbal pieces with modern technology, resulting in the birth of broken Chinese herbal pieces represented by "Cao Jinghua", which has brought great changes to the Chinese medicine industry.

Established in 1993, CIIC Pharmaceutical Co., Ltd. is a scientific and technological pharmaceutical enterprise integrating medical research, production and sales. Over the years, the company has adhered to the innovation-driven strategy and attached great importance to scientific and technological innovation. At present, 15 national and provincial science and technology innovation platforms have been built, a number of characteristic products with independent intellectual property rights have been developed, and new categories of Chinese herbal pieces have been created, effectively promoting the transformation and upgrading of the Chinese medicine industry. In Cheng's view, Zhongzhi Pharmaceutical is not only the inventor of the technology of Chinese herbal pieces, but also the pioneer of new varieties of Chinese herbal pieces.

Innovating science and technology, Chinese medicine shines brilliantly

It is understood that in 2003, Zhongzhi Pharmaceutical began to tackle the technical problems of Chinese herbal pieces. After 10 years of research and exploration, we finally successfully developed two core technologies: wall-breaking and plastic surgery without additives. On this basis, Zhongzhi Pharmaceutical has built a number of deep and fine processing production lines from stems, branches and powders of Chinese herbal medicines to Chinese herbal pieces, and processed Chinese herbal medicines with standardized production processes and modern management processes. At present, Zhongzhi Pharmaceutical Co., Ltd. has developed three product series of Chinese herbal pieces, Chinese patent medicines and health food with independent intellectual property rights, which has become a banner of Chinese medicine innovation.

"Breaking its shape and keeping its marrow" is to break the cell wall of traditional Chinese medicine into broken powder by ultra-fine pulverization technology, and then make it into particles by non-additive molding technology. It is convenient and quick to take it directly with water. Cheng introduced that the effective components of traditional Chinese medicine were completely released by cell wall breaking to form powder, which solved the problem of curative effect of traditional Chinese medicine. On the basis of powder, making granules without excipient technology can effectively overcome the shortcomings of easy caking and oxidation of powder medicine and solve the problem of drug stability, so as to obtain modern Chinese medicine products with controllable quality, uniform substance and accurate measurement.

Not only that, Cizhi Pharmaceutical has been committed to the modern transformation of Chinese medicine industry, attached great importance to technological innovation, and constantly increased R&D investment. Only 20 17 a year, the company's R&D investment reached 34.5 million yuan, which is rare in Chinese medicine enterprises. At the same time, as one of the earliest Industry-University-Research cooperative enterprises in Guangdong Province, CIIC has successively cooperated with Guangzhou University of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine of China Academy of Traditional Chinese Medicine, Shanghai Institute of Pharmacology of China Academy of Sciences, Macau University of Science and Technology and other scientific research institutions and universities. In addition, Cizhi Pharmaceutical Co., Ltd. also took the lead in establishing the "Technical Innovation Alliance of Chinese Herbal Pieces Industry", established a series of scientific research platforms such as the Postdoctoral Research Center for the Technology and Application of Chinese Herbal Pieces and the State Key Research Laboratory, and continued to carry out research on the development of Chinese herbal medicine resources, production quality control, drug safety and stability, international and domestic quality standards of Chinese herbal medicines, and gained a firm foothold in the industry.

Pay attention to the layout of intellectual property rights and highlight the value.

The data shows that the market scale of Chinese herbal pieces reached 25.6 billion yuan in 20 17, up 10.5% year-on-year. It is estimated that the sales scale in 20 18 will exceed 27 billion yuan. Aiming at this huge market, Zhongzhi Pharmaceutical has launched a series of products called "Cao Jinghua". This product has been well received by customers since it went on the market on 20 12, with a compound growth rate of 73.96%. It is far ahead in the Chinese herbal medicine market and has become the fist product and representative brand of Zhongzhi Pharmaceutical. Cizhi pharmaceutical people clearly realize that protecting the achievements of independent innovation will help to maintain the leading position in the market. Therefore, leading the development of enterprises with core technologies is a top priority for CIIC at this stage.

"Cizhi Pharmaceutical has initially formed an intellectual property work system that is compatible with the company's scientific research and innovation and its own business development, established a special intellectual property management team, and hired external legal consultants to assist the company in carrying out related work. In recent years, the company has formulated an intellectual property management system and a reward system, regularly carried out patent knowledge training, evaluated scientific research and innovation achievements, actively carried out patent mining and patent application, gradually improved the patent layout, and initially established an intellectual property early warning and risk prevention mechanism, which provided a strong guarantee for the company to independently research and develop core technologies, and also played a positive role in promoting the brand building of high-tech products such as Cao Jinghua. " Cheng said to him.

At present, Zhongzhi Pharmaceutical Co., Ltd. has submitted patent applications for many core technologies, such as decoction pieces of traditional Chinese medicine, quality control of fingerprint of traditional Chinese medicine, and secondary development of traditional Chinese medicine, and made patent layout from many dimensions, such as traditional Chinese medicine products, production technology, quality control, product packaging, etc., in an attempt to gradually build a patent pool based on authorized patents, with a view to comprehensively protecting the company's innovation achievements and laying the foundation for patent operation in the field of traditional Chinese medicine in the future. According to Cheng, Cizhi Pharmaceutical Co., Ltd. has submitted more than 80 patent applications for Chinese herbal pieces, including Chinese mainland, Hongkong, Macao Special Administrative Region and Taiwan Province Province. In 20 17, the company was recognized as a "national intellectual property advantage enterprise" and won the 19th China Patent Excellence Award 1, Zhongshan Patent Gold Award 1 and Zhongshan Patent Excellence Award 2.

"Zhongzhi Pharmaceutical will continue to hold high the banner of scientific and technological innovation, continue to lead the modern transformation of the Chinese medicine decoction pieces industry, strive to promote the establishment of national and international standards for Chinese medicine decoction pieces, continue to increase investment in research and development, attach great importance to intellectual property rights, and constantly improve the patent layout." Cheng said that in the future, Cizhi Pharmaceutical will further strengthen the layout of overseas patents and provide assistance for the company to actively explore overseas markets.

comment

As a high-tech small and medium-sized enterprise in the field of medicine, CIIC Pharmaceutical aims at the development goal, takes "Cao Jinghua" as the research and development core and breakthrough point, and constantly makes technical breakthroughs, finally making a major breakthrough, creating a new category of Chinese herbal pieces, realizing the standardization of "non-standard products" and winning the best opportunity for its rapid development. CIMC has successfully embarked on a road of modernization and transformation of Chinese medicine enterprises, which can be summarized as: relying on independent innovation, mastering core technologies, attaching importance to intellectual property rights, building technical barriers and speeding up patent layout. Its successful development experience can be used for reference by other enterprises in the industry. (Sudan)

2065438+September 26, 2008 Pei Su Hongdan